Manual. Manual Welsh Eye Care Initiative. A Welsh Eye Care Initiative. Protocol. The Assessment and Management of Age-related Macular Degeneration

Size: px
Start display at page:

Download "Manual. Manual Welsh Eye Care Initiative. A Welsh Eye Care Initiative. Protocol. The Assessment and Management of Age-related Macular Degeneration"

Transcription

1 A Protocol 1.0 Definitions The following terms are important in this text: Wet Macular Degeneration Condition caused by the growth of abnormal blood vessels under the retina. Symptoms appear suddenly and progress over days or weeks. Person complains of distorted central vision. The most important signs are subretinal fluid and haemorrhage. Disciform macular scar The end-stage of wet macular degeneration occurs in 90% of cases without treatment. Person has a blank patch in the centre of their vision. The most important sign is an elevated patch of scar tissue centered on the macula. Dry Macular Degeneration Condition caused by the accumulation of waste products under the retinal pigment epithelium. Symptoms develop gradually and progress over months or years. Most people are asymptomatic but may eventually complain of difficulty reading and poor vision in dim light. The most important signs are drusen, pigment epithelial atrophy and pigment clumping (so-called pigmentary changes). The Assessment and Management of Age-related Macular Degeneration Geographic atrophy The end-stage of dry macular degeneration occurs in about 10% of cases. Person has a blank patch in the centre of their vision. The most important sign is a roughly circular, flat or slightly depressed pale area centered on the macula. Recent Within the last three months.

2 2.0 Optometric assessment and management The frequency and composition of optometric assessment and the management protocols for different groups of patients with macular changes and/ or degeneration is summarised in this section. 2.1 Category A Macular changes without visual problem If a patient is aged over 55 years and has macular changes without visual problem they should be followed up regularly and given appropriate advice. 1) Recording findings - Macular signs should be recorded diagrammatically and/or using a photograph if a fundus camera is available 2) Recall - Recall in one year for Private or GOS Eye Examination (using code 2.0 if required) depending on eligibility. 3) Information - Inform the person about the retinal signs and give advice about how to monitor for reduced or distorted vision and return promptly if a change is noticed. 4) Advice - Advise the person about the benefits of a healthy diet and if they smoke explain the increased risk associated with the development of macular degeneration. 2.2 Category B VA 6/60 with recent onset symptoms or retinal signs A PEARS examination should be carried out to differentiate between treatable and non- treatable macular degeneration Any patient with visual acuity of 6/60 or better in the affected eye and: or suspected onset of macular degeneration due to retinal signs and recent visual loss or distortion previously recorded macular changes or degeneration presenting with recent visual loss or distortion should be examined at the earliest opportunity to differentiate treatable and non treatable macular degeneration. The PEARS examination should include: Symptoms and History Symptoms Duration of visual changes Description of visual changes Which eye? Ocular History Previous optometric investigation Previous ophthalmological investigation/ treatment Previous low vision intervention General Health Smoking history (current, ex-smoker or non-smoker) High blood pressure or treatment for high blood pressure Family Ocular History Family History of macular degeneration

3 Clinical Examination (of both eyes) Best corrected distance and near monocular visual acuity Potentially treatable Wet Macular Degeneration Refer urgently by telephone the same day (see referral pathways below) Refraction Management Pupil responses to light Anterior chamber angle assessment Contact Tonometry Dilation using Tropicamide 1% and Phenylephrine 2.5% Stereoscopic fundus examination using a slit lamp biomicroscope and a 60D lens noting the presence or absence of the following signs: - Macular drusen - Pigmentary changes - Retinal thickening (oedema and exudates) - Sub-RPE or sub-retinal fluid - Sub-RPE, sub-retinal, intra-retinal and pre-retinal haemorrhages - Fibrosis - Features of other conditions e.g. angioid streaks A fundus photograph if a camera is available In order to manage the person appropriately practitioners must use the signs and symptoms to decide if the patient is presenting with: Potentially treatable Wet Macular Degeneration Dry Macular Degeneration or Other pathology Dry Macular Degeneration 1) Information- Inform the patient about dry macular degeneration and provide them with an information booklet or tape 2) Refer Low Vision- If both eyes are affected and the person has best corrected Binocular Distance VA < 6/9 or Near < N6 they should be offered referral to the all Wales Low Vision Service (WLVS) 3) Registration- If eligible, the person should be advised of the process and benefits of registration and offered referral for this. 4) Monitor- Advise the person how to monitor for reduced or distorted vision and return promptly if a change is noticed. 5) Diet and Nutrition- Advise the person about the benefits of a healthy diet for all and the finding that nutritional supplements halt progression in some cases. 6) Smoking- If the person smokes advise them to stop smoking and provide them with details of local support networks to do this. 7) Driving- If the person's vision is outside the legal requirements for driving they should be advised to stop driving. 8) Social Services- If you are concerned that the person is at risk to themselves or others (e.g. burning, falling, medication) then they should be referred urgently to social services. Otherwise referral will be initiated by the low vision service. 9) Recall- Recall in one year for a Welsh Eye Health Examination. Other pathology Other pathology should be managed according to agreed local and national protocols and/ or guidelines

4 2.3 Category C VA 6/60 in either eye without recent onset or change Patients in this group have untreatable Macular Degeneration but they may develop treatable wet Macular Degeneration in future. Therefore, they should be monitored closely. A WEHE examination should be carried out to rule of any signs of treatable disease and the management is essentially the same as that outlined in 2.2 for those diagnosed as having dry Macular Degeneration. 1) Recording findings - Macular signs should be recorded diagrammatically and/ or using a photograph if a fundus camera is available 2) Information- Inform the patient about macular degeneration and provide them with an information booklet or tape. 3) Low Vision- If both eyes are affected and the person has best corrected Binocular Distance VA < 6/9 or Near < N6 they should be offered referral to the all Wales Low Vision Service (WLVS) 4) Registration- If eligible, the person should be advised of the process and benefits of registration and offered referral for this. 5) Monitor- Advise the person how to monitor for reduced or distorted vision and return promptly if a change is noticed. 6) Diet and Nutrition- Advise the person about the benefits of a healthy diet for all and the finding that nutritional supplements slow progression in some cases. 7) Smoking- If the person smokes advise them to stop smoking and provide them with details of local support networks to do this. 8) Driving- If the person's vision is outside the legal requirements for driving they should be advised to stop driving. 9) Social Services- If you are concerned that the person is at risk to themselves or others (e.g. burning, falling, medication) then they should be referred urgently to social services. Otherwise referral will be initiated by the low vision service. 2.4 Category D Binocular VA < 6/60 Patients in this group have untreatable Macular Degeneration and due to current NHS protocols will not be offered treatment. Therefore, they should be monitored using the GOS system to ensure that any other ocular pathology is detected at the earliest opportunity and that they are receiving appropriate rehabilitation for their needs. 1) Information- Inform the patient about macular degeneration and provide them with an information booklet or tape. 2) Low Vision- Ensure patients have been offered referral to the all Wales Low Vision Service (WLVS) and check this at each opportunity. 3) Registration- Registration status should be checked at each visit and the person offered referral for initiation of registration or to change their status from sight impaired to severely sight impaired if appropriate. 4) Monitor- Advise the person of the importance of regular eye tests to detect other abnormal ocular conditions. 5) Diet and Nutrition- Advise the person about the benefits of a healthy diet for all and the finding that nutritional supplements slow progression in some cases. 6) Smoking- If the person smokes advise them to stop smoking and provide them with details of local support networks to do this. 7) Driving- The person should be advised that they are outside legal visual requirements for driving. 8) Social Services- If you are concerned that the person is at risk to themselves or others (e.g. burning, falling, medication) then they should be referred urgently to social services. Otherwise referral will be initiated by the low vision service. 9) Recall- Recall using GOS recommended intervals. 10) Recall- Recall in one year for a Welsh Eye Health Examination.

5 3.0 Referral Pathways The referral pathways for different services and urgency of referral for patients with macular degeneration living in Wales is summarised in this section. 3.1 Urgent Referral of Potentially Treatable Wet Macular Degeneration Patients with potentially treatable Macular Degeneration should be referred the same day by telephone or fax (depending on the centre). 3.5 Referral to Social Services Anyone who is at risk to themselves or others (e.g. due to risk of burning, falling, or taking medication incorrectly) then they should be referred urgently to social services. Contact details for social services teams are updated regularly on the website When referring people urgently it is essential to make it clear that you want to refer the person urgently giving reasons for this. Routine rehabilitative support will be initiated by the low vision service. Practitioners may wish to use one of the Rapid Access Referral Forms (See Appendix 1) prior to phoning so that they have all the relevant information to hand. This referral may also be faxed or posted to the relevant hospital. Contact details for Wales are listed in Appendix 2 and on the website Routine Referral of Non Treatable Macular Degeneration Patients who have Macular Degeneration that is not treatable who request an ophthalmological opinion should be referred to a local Hospital Eye Service routinely using normal the normal referral pathway. 3.3 Referral for Registration Patients who are eligible and would like to be registered or have their registration status changed should be referred to a Consultant Ophthalmologist in the local Hospital Eye Service. Give details of factors making the person especially vulnerable, for example profoundly deaf, living alone etc. 3.4 Referral for a Low Vision Assessment Patients who would like to have a low vision assessment should be referred to a community based WLVS in the first instance. Waiting times should be less than two weeks for most people. Contact details for services are updated regularly on the website or can be obtained by phoning the Administration team in Carmarthen LHB

A service and clinical guide for the Eye Health Examination Wales (EHEW) part of the Wales Eye Care Service (WECS)

A service and clinical guide for the Eye Health Examination Wales (EHEW) part of the Wales Eye Care Service (WECS) A service and clinical guide for the Eye Health Examination Wales (EHEW) part of the Wales Eye Care Service (WECS) For optometrists and ophthalmic medical practitioners (OMPs) Issued by the Welsh Government

More information

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina

The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to

More information

Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent

Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent Patient information Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent Introduction You have an eye condition called

More information

Ophthalmology. Ophthalmology Services

Ophthalmology. Ophthalmology Services Ophthalmology Ophthalmology Services The Ophthalmology service offers the latest and most comprehensive eye care for patients. With a dedicated team of eye surgeons and consultants, we treat vision problems

More information

Primary Eyecare Acute Referral Scheme (PEARS) Accreditation

Primary Eyecare Acute Referral Scheme (PEARS) Accreditation Primary Eyecare Acute Referral Scheme (PEARS) Accreditation Barbara Ryan and Nick Sheen Directors, Wales Optometry Postgraduate Education Centre 2011 1.0 Summary of PEARS Training and Accreditation LOCSU

More information

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES

DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES DIRECT REFERRAL OF CATARACT PATIENTS COMMUNITY OPTOMETRIST PROTOCOL AND GUIDELINES October 2013 Preoperative assessment History Symptoms/social history: is the patient visually affected and do they want

More information

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009 LOCSU Community Services Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway Issued by Local Optical Committee Support Unit May 2009 [Revised May 2016, Version 3.3] Contents Page Executive

More information

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009

LOCSU Community Services. Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway. Issued by Local Optical Committee Support Unit May 2009 LOCSU Community Services Glaucoma Repeat Readings & OHT Monitoring Community Service Pathway Issued by Local Optical Committee Support Unit May 2009 [Revised November 2013] Contents Page Executive Summary...

More information

MECS/EHEW OSCE candidate information

MECS/EHEW OSCE candidate information Overview The Part 2 practical assessment is a series of Objective Structured Clinical Examinations or OSCEs. This is a type of examination regularly used in medical training to test skills such as communication,

More information

OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines

OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines OPHTHALMOLOGY DEPARTMENT Primary care referral guidelines Contents REFERRAL CATEGIES... 2 Emergency... 2 Urgent... 2 Semi urgent/routine... 2 Not accepted... 2 OPHTHALMOLOGY CONDITIONS NOT ACCEPTED...

More information

GENERAL INFORMATION DIABETIC EYE DISEASE

GENERAL INFORMATION DIABETIC EYE DISEASE GENERAL INFORMATION DIABETIC EYE DISEASE WHAT IS DIABETIC EYE DISEASE? Diabetic eye disease is a term used to describe the common eye complications seen in people with diabetes. It includes: Diabetic retinopathy

More information

Quality in Optometry Record Card Keeping.

Quality in Optometry Record Card Keeping. Quality in Optometry Record Card Keeping. The Quality in Optometry (QIO) visits to practices commenced in May 2018. During this time we have noticed reoccurring themes and thought it would be helpful to

More information

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Medical Retina November 2016 Association of Health Professions in Ophthalmology General basic

More information

Sponsored by. Shared care and referral pathways. Part 5: referring AMD easy as 1,2,3

Sponsored by. Shared care and referral pathways. Part 5: referring AMD easy as 1,2,3 CET CONTINUING Sponsored by 1 CET POINT Shared care and referral pathways Part 5: referring AMD easy as 1,2,3 Chris Steele BSc (Hons), FCOptom, DCLP, DipOC, DipTp(IP), FBCLA The National Institute for

More information

For details on measurement and recording of visual acuity, refer to Annex 1. VISION INTERPRETING RESULTS ABSTRACT

For details on measurement and recording of visual acuity, refer to Annex 1. VISION INTERPRETING RESULTS ABSTRACT management update on functional decline in older adults 2012 Unit No. 5 VISION Dr Au Eong Kah Guan, Ms Yulianti, Ms Fifiana ABSTRACT Among Singaporean adults of Chinese origin aged 40 to 79 years old,

More information

GLAUCOMA REPEAT READINGS PATHWAY

GLAUCOMA REPEAT READINGS PATHWAY GLAUCOMA REPEAT READINGS PATHWAY Level 1a: Goldmann style applanation tonometry repeat readings A first level community service for IOP refinement where other signs of glaucoma are not present will reduce

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #14 (NQF 0087): Age-Related Macular Degeneration (AMD): Dilated Macular Examination National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Diabetic Eye Disease

Diabetic Eye Disease Manchester Royal Eye Hospital Medical Retinal Services Information for Patients Diabetic Eye Disease This leaflet sets out to answer some of your questions about diabetic eye disease. You may wish to discuss

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Quality ID #14 (NQF 0087): Age-Related Macular Degeneration (AMD): Dilated Macular Examination National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY

More information

Central Mersey Diabetic Retinopathy Screening Programme. Referring patients for Diabetic Retinopathy Screening

Central Mersey Diabetic Retinopathy Screening Programme. Referring patients for Diabetic Retinopathy Screening Central Mersey Diabetic Retinopathy Screening Programme Referring patients for Diabetic Retinopathy Screening Information for GPs in Halton & St Helens, Knowsley and Warrington PCT Version: June 2008 Review

More information

DIABETIC RETINOPATHY

DIABETIC RETINOPATHY THE UK GUIDE DIABETIC RETINOPATHY Everything you need to know about diabetic retinopathy Jaheed Khan BSc (Hons) MBBS MD FRCOphth Fellow of the Royal College of Ophthalmologists Association for Research

More information

Posterior Segment Update

Posterior Segment Update Posterior Segment Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens function is to focus

More information

LOCSU Community Services

LOCSU Community Services LOCSU Community Services Pre- and Post-Operative Cataract Community Service Pathway Issued by Local Optical Committee Support Unit December 2008 [Revised 14 March 2016, Version 3.2] Contents Page Outline

More information

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal Perspectives on Screening for Diabetic Retinopathy 1 Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal Current standards 2 According to the Canadian Diabetes

More information

Diabetic Retinopathy. What should know

Diabetic Retinopathy. What should know Diabetic Retinopathy What should know Diabetic Retinopathy: What you should know This booklet is for people with diabetic retinopathy and their families and friends. It provides information about diabetic

More information

Screening for Uveitis in Children

Screening for Uveitis in Children Information for patients and parents Manchester Royal Eye Hospital Paediatric Uveitis Service Screening for Uveitis in Children What is uveitis? Uveitis is inflammation of a layer of the eye, called the

More information

What is Age-Related Macular Degeneration?

What is Age-Related Macular Degeneration? Intravitreal Injections Eylea / Lucentis Patient Information What is Age-Related Macular Degeneration? Age-related macular degeneration (AMD) is an eye condition found in older people, which may lead to

More information

UVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS

UVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS Information for patients UVEITIS CLINIC UVEITIS IN GENERAL WHAT IS UVEITIS? The uvea is a name given to the pigmented layer of tissue inside the eye. When all or part of the uvea becomes inflamed, the

More information

Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration (AMD) Age-Related Macular Degeneration (AMD) What is the Macula? What is Dry AMD (Age-related Macular Degeneration)? Dry AMD is an aging process that causes accumulation of waste product under the macula leading

More information

Examining the Eyes. Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals

Examining the Eyes. Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals Examining the Eyes Mr. Nicholas Lee Lead Clinician Consultant Ophthalmologist at Hillingdon and The Western Eye Hospitals Ophthalmology - Eyes Ophthalmology Medical - Busiest outpatient department Glaucoma

More information

Ophthalmology Unit Referral Guidelines

Ophthalmology Unit Referral Guidelines Ophthalmology Unit Referral Guidelines Austin Health Ophthalmology Unit holds sub-specialty sessions to discuss and plan the treatment of patients with specific ocular conditions. General including cataract

More information

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY? Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? Diabetic retinopathy affects 8 million Americans with diabetes. A leading cause of blindness in American adults, it is caused by damage to the small blood

More information

NHS Diabetic Eye Screening Programme

NHS Diabetic Eye Screening Programme NHS Diabetic Eye Screening Programme Slit lamp examination Public Health England leads the NHS Screening Programmes Who is this leaflet for? This leaflet is for people who need to be examined for diabetic

More information

Guidance for Optometrists in relation to Diabetic Retinopathy Screening Schemes. June 2004

Guidance for Optometrists in relation to Diabetic Retinopathy Screening Schemes. June 2004 Guidance for Optometrists in relation to Diabetic Retinopathy Screening Schemes June 2004 Over the next few years formal screening schemes designed to detect diabetic retinopathy will be introduced across

More information

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features

More information

Your guide to diabetic eye screening

Your guide to diabetic eye screening Your guide to diabetic eye screening Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Speaker Disclosure Statement. " Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose.

Speaker Disclosure Statement.  Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Speaker Disclosure Statement Dr. Tim Maillet and Dr. Vladimir Kozousek have no conflicts of interest to disclose. Diabetes Morbidity Diabetes doubles the risk of stroke. Diabetes quadruples the risk of

More information

amendments to the NHS (General Ophthalmic Services) (Scotland) Regulations 2006 ( the 2006 Regulations ); and

amendments to the NHS (General Ophthalmic Services) (Scotland) Regulations 2006 ( the 2006 Regulations ); and NHS: PCA(O)(2014)1 Health and Social Care Integration Directorate Primary Care Division Dear Colleague GENERAL OPHTHALMIC SERVICES 1. THE NHS (GENERAL OPHTHALMIC SERVICES) (SCOTLAND) AMENDMENT REGULATIONS

More information

OUR EYES & HOW WE SEE

OUR EYES & HOW WE SEE OUR EYES & HOW WE SEE UNDERSTAND MORE ABOUT OUR EYES & HOW WE SEE Our Eyes & How We See The eye is our visual gateway to the world. Within it, an array of delicate components labour away to give us the

More information

The Future of Optometric Services in Primary Care in Wales

The Future of Optometric Services in Primary Care in Wales IMPROVING HEALTH IN WALES The Future of Optometric Services in Primary Care in Wales a consultation document ISBN 0 7504 2968 2 Designed by CartoGraphic Services G/254/02-03 September 2002 INA - 15-02

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens s function is to focus

More information

VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz)

VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz) PATIENT INFORMATION BOOKLET PAGE 1 OF 32 VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz) AN INTRAOCULAR TELESCOPE FOR TREATING SEVERE TO PROFOUND VISION IMPAIRMENT DUE TO BILATERAL

More information

Diabetes Retinopathy Extension Dataset

Diabetes Retinopathy Extension Dataset For reference only Do Not Use For more information contact: cdsis@nhs.net Diabetes Retinopathy Extension Dataset March 2006 National Clinical Dataset Development Programme (NCDDP) Support Team Information

More information

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA Vision 2020 Australia Vision Initiative RANZCO & OAA (Vic) Proud members of Vision 2020 Australia Outline Vision

More information

Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients

Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients Ophthamology Directorate Eye Injection for Macular Disorders Information for Patients As discussed at your appointment today, please call the Medical Retinal Services Coordinator as soon as possible (within

More information

Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project

Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project 410 Department of Ophthalmology, University of Melbourne, Melbourne, Australia C A McCarty C W Lloyd-Smith P M Livingston Y L Stanislavsky H R Taylor Victorian WorkCover Authority, Melbourne, Australia

More information

RETINAL DETACHMENT AT THE POSTERIOR POLE*

RETINAL DETACHMENT AT THE POSTERIOR POLE* Brit. J. Ophthal. (1958) 42, 749. RETINAL DETACHMENT AT THE POSTERIOR POLE* BY CALBERT I. PHILLIPSt Institute of Ophthalmology, University oflondon THE common feature of the cases to be described in this

More information

Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study

Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study Br J Ophthalmol 2001;85:1153 1157 1153 WORLD VIEW (Series editor: Emmett T Cunningham Jr) Department of Ophthalmology, Faculty of Medicine, Kyushu University, Fukuoka, Japan Y Oshima T Ishibashi T Murata

More information

PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS

PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS PRESCRIBING IN GLAUCOMA: GUIDELINES FOR NZ OPTOMETRISTS Introduction Independent prescribing relates to the capacity to use clinical judgement in respect of diagnosis and treatment. It does not mean working

More information

Year 2 MBChB Clinical Skills Session Ophthalmoscopy. Reviewed & ratified by: Mr M Batterbury Consultant Ophthalmologist

Year 2 MBChB Clinical Skills Session Ophthalmoscopy. Reviewed & ratified by: Mr M Batterbury Consultant Ophthalmologist Year 2 MBChB Clinical Skills Session Ophthalmoscopy Reviewed & ratified by: o Mr M Batterbury Consultant Ophthalmologist Learning objectives o To understand the anatomy and physiology of the external and

More information

Macular hole. Information for patients Ophthalmology (Vitreal Retina) Large Print

Macular hole. Information for patients Ophthalmology (Vitreal Retina) Large Print Macular hole Information for patients Ophthalmology (Vitreal Retina) Large Print page 2 of 16 What is the macula? The back of the eye has a light-sensitive lining called the retina, similar to the film

More information

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan Long-term Management of AMD Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan DEFINITION 1 Age-related macular degeneration (AMD) is a disorder of the macula characterized

More information

Age-Related. macular degeneration.

Age-Related. macular degeneration. Age-Related Macular Degeneration This pamphlet is designed to help people with age-related macular degeneration and their families better understand the disease. It describes the causes, symptoms, diagnosis,

More information

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people Diabetic Retinopathy What is diabetic eye disease? Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss

More information

Glaucoma What You Should Know

Glaucoma What You Should Know Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads

More information

Preparing for laser treatment for diabetic retinopathy and maculopathy

Preparing for laser treatment for diabetic retinopathy and maculopathy Preparing for laser treatment for diabetic retinopathy and maculopathy Information for patients Preparing for laser treatment for diabetic retinopathy and maculopathy. This leaflet sets out to answer the

More information

OPHTHALMOLOGICAL DISORDERS

OPHTHALMOLOGICAL DISORDERS Telephone No.: 24622495 Telegraphic Address: Aeronautical: VIDDYAYX Commercial: AIRCIVIL NEW DELHI E Mail: dri@dgca.nic.in Fax:01124629211 GOVERNMENT OF INDIA AERONAUTICAL INFORMATION SERVICE DIRECTOR

More information

Diabetic Retinopathy Screening Programme

Diabetic Retinopathy Screening Programme Diabetic Retinopathy Screening Programme Information for patients As you have diabetes, your GP has arranged for you to attend the Diabetic Retinopathy Screening Service. This service is free and is provided

More information

Common Causes of Vision Loss

Common Causes of Vision Loss Common Causes of Vision Loss Learning Objectives To identify the most common causes of vision loss in the United States To differentiate the most common forms of agerelated macular degeneration and diabetic

More information

Ophthalmology. Caring For Your Eyes. Jurong Medical Centre

Ophthalmology. Caring For Your Eyes. Jurong Medical Centre Ophthalmology Caring For Your Eyes Jurong Medical Centre Your eyes and you At Jurong Medical Centre, we have a dedicated team of ophthalmologists that specialise in treating a wide range of acute and chronic

More information

GRADUAL LOSS OF VISION. Teresa Anthony Consultant Ophthalmologist Emersons Green NHS Treatment Centre Bristol

GRADUAL LOSS OF VISION. Teresa Anthony Consultant Ophthalmologist Emersons Green NHS Treatment Centre Bristol GRADUAL LOSS OF VISION Teresa Anthony Consultant Ophthalmologist Emersons Green NHS Treatment Centre Bristol CVI Registration Low Vision: 6/60 Sight impaired: 3/60 Severe sight impaired:

More information

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection Information for Patients Manchester Royal Eye Hospital Medical Retina Services Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection What is age related macular degeneration (AMD)?

More information

MAGNITUDE OF DIABETIC EYE DISEASE IN INDIA

MAGNITUDE OF DIABETIC EYE DISEASE IN INDIA Dear Doctor This booklet contains information about your role as a physician in preventing blindness in your diabetic patients. You are the first point of contact for your diabetic patients. You see them

More information

RETINAL CONDITIONS RETINAL CONDITIONS

RETINAL CONDITIONS RETINAL CONDITIONS GENERAL INFORMATION RETINAL CONDITIONS RETINAL CONDITIONS WHAT ARE RETINAL CONDITIONS? Retinal conditions affect the light-sensitive tissue at the back of eye known as the retina. They include diseases

More information

Prevention and treatment of agerelated macular degeneration

Prevention and treatment of agerelated macular degeneration THERAPY REVIEW Prevention and treatment of agerelated macular degeneration SARAH HORTON AND CATHERINE GULY Age-related macular degeneration (AMD) is a common cause of visual loss in older people and GPs

More information

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening linical Guidelines Hydroxychloroquine and hloroquine Retinopathy: Recommendations on Screening February 2018 - Review date: February 2021 Executive Summary Recent data have highlighted that hydroxychloroquine

More information

CENTRAL MERSEY LOCAL OPTICAL COMMITTEE

CENTRAL MERSEY LOCAL OPTICAL COMMITTEE CENTRAL MERSEY LOCAL OPTICAL COMMITTEE OPTOMETRIC REFERRAL GUIDELINES The ocular conditions listed in this document are intended to reflect those that might be encountered in optometric practice and this

More information

Mild NPDR. Moderate NPDR. Severe NPDR

Mild NPDR. Moderate NPDR. Severe NPDR Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in

More information

Pigmented lesions of the

Pigmented lesions of the Pigmented lesions of the choroid and retina are commonly encountered by optometrists in everyday practice. The increasing use of retinal imaging and indirect ophthalmoscopy among community optometrists

More information

Sponsored by. Shared care and referral pathways Part 3: See through cataract referral

Sponsored by. Shared care and referral pathways Part 3: See through cataract referral CET CONTINUING Sponsored by 1 CET POINT Shared care and referral pathways Part 3: See through cataract referral Chris Steele BSc (Hons), FCOptom, DCLP, DipOC, DipTp(IP), FBCLA Cataract surgery is the most

More information

Diabetes & Your Eyes

Diabetes & Your Eyes Diabetes & Your Eyes Diabetes is a disease that occurs when the pancreas does not secrete enough insulin or the body is unable to process it properly. Insulin is the hormone that regulates the level of

More information

Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR)

Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Preserve Vision Information Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Regular examination by your ophthalmologist will allow early detection and treatment. Age-related Macular

More information

Diabetic Eye Screening

Diabetic Eye Screening Diabetic Eye Screening Lorraine Lockwood Engagement Manager Health Intelligence Classification: Internal / Public 26/10/16 Who we are (EDESP) formed on 1 st April 2016 Who should be screened? All patients

More information

What You Should Know About Angioid Streaks By David J. Browning, MD, PhD

What You Should Know About Angioid Streaks By David J. Browning, MD, PhD What You Should Know About Angioid Streaks By David J. Browning, MD, PhD The eye wall has several layers, as shown in figure 1. Proceeding from the inside of the eye to the outside, the layers are as follows:

More information

Community Eye Care Pathway Developments in South Staffs (or: How we Bridge the North/South Divide )

Community Eye Care Pathway Developments in South Staffs (or: How we Bridge the North/South Divide ) Community Eye Care Pathway Developments in South Staffs (or: How we Bridge the North/South Divide ) Mark McCracken Joint Vice Chair (South) Staffordshire LOC Staffordshire Community Eye Care Pathways North

More information

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre 11:00-11:55 WS #115: The Revolution in Macular Degeneration Management 12:05-13:00 WS #127: The Revolution in Macular

More information

Abstract title: Vision loss from myelinated retinal nerve fiber layer with maculopathy. Authors: Man Kin (Eric) Chow, OD Lori Vollmer, OD, FAAO

Abstract title: Vision loss from myelinated retinal nerve fiber layer with maculopathy. Authors: Man Kin (Eric) Chow, OD Lori Vollmer, OD, FAAO Abstract title: Vision loss from myelinated retinal nerve fiber layer with maculopathy. Authors: Man Kin (Eric) Chow, OD Lori Vollmer, OD, FAAO Joseph Sowka, OD, FAAO General Topic: Ocular Disease Primary

More information

Photocoagulation of disciform macular lesions

Photocoagulation of disciform macular lesions British Journal of Ophthalmology, 1979, 63, 669-673 Photocoagulation of disciform macular lesions with krypton laser A. C. BIRD AND R. H. B. GREY From the Institute of Ophthalmology, Moorfields Eye Hospital,

More information

A population based study of macular choroidal neovascularization using optical coherence tomography in Eastern China

A population based study of macular choroidal neovascularization using optical coherence tomography in Eastern China EXPERIMENTAL AND THERAPEUTIC MEDICINE 8: 371-376, 2014 A population based study of macular choroidal neovascularization using optical coherence tomography in Eastern China JIE ZHAO, JUN HU, HAO LU and

More information

Atrophic AMD with Vitreomacular Traction Syndrome.

Atrophic AMD with Vitreomacular Traction Syndrome. Case Record 5 Atrophic AMD with Vitreomacular Traction Syndrome. June 2012 Dr Peter Frampton DOptom MSc FCOptom BAppSc(Optom)(AUS) DipTp(AS) DipTp(SP) DipTp(IP) Introduction : New Diagnostic Technologies

More information

Ophthalmology Macular Pathways

Ophthalmology Macular Pathways Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological

More information

PATIENT INFORMATION LEAFLET MACULAR HOLE. What is the macula?

PATIENT INFORMATION LEAFLET MACULAR HOLE. What is the macula? What is the macula? The back of the eye has a light-sensitive lining called the retina, similar to the film in a camera. Light is focused through the eye onto the retina, allowing us to see. The centre

More information

MANAGING DIABETIC RETINOPATHY. <Your Hospital Name> <Your Logo>

MANAGING DIABETIC RETINOPATHY. <Your Hospital Name> <Your Logo> MANAGING DIABETIC RETINOPATHY It s difficult living with Diabetes Mellitus. Ask any diabetic... Their lives are centered around meal plans, glucose levels, and insulin

More information

Diabetic Retinopathy Screening in Hong Kong. Dr. Rita Gangwani M.S, FRCS (Ophth), FCOphth(HK), FHKAM Eye Institute, The University of Hong Kong

Diabetic Retinopathy Screening in Hong Kong. Dr. Rita Gangwani M.S, FRCS (Ophth), FCOphth(HK), FHKAM Eye Institute, The University of Hong Kong Diabetic Retinopathy Screening in Hong Kong Dr. Rita Gangwani M.S, FRCS (Ophth), FCOphth(HK), FHKAM Eye Institute, The University of Hong Kong Co-Investigators Prof. David Wong Prof. Sarah McGhee Dr. Wico

More information

The Human Eye. Cornea Iris. Pupil. Lens. Retina

The Human Eye. Cornea Iris. Pupil. Lens. Retina The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in

More information

Reducing vision loss in chronic eye disease

Reducing vision loss in chronic eye disease THEME vision at risk Anthony Fong MBBS, BOptom, is Clinical Fellow, City Eye Centre, Brisbane, Queensland. antfong@ hotmail.com Graham Lee MD, MBBS, FRANZCO, is Associate Professor, The University of Queensland.

More information

Diabetic Retinopathy Information

Diabetic Retinopathy Information http://www.midwestretina.com Phone: (614)-339-8500 Toll Free: (866)-373-8462 Sugat S. Patel, M.D. Louis J. Chorich III, M.D. Dino D. Klisovic, M.D. Lisa M. Borkowski, M.D. Dominic M. Buzzacco, M.D. Johnstone

More information

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features

More information

OAKLEIGH EYE CENTRE. THE EYE Before looking at diabetic retinopathy it is important to understand what the healthy eye looks like and how it works.

OAKLEIGH EYE CENTRE. THE EYE Before looking at diabetic retinopathy it is important to understand what the healthy eye looks like and how it works. ABN: 80 836 359 971 Dr Mark Steiner 345 799X 135 Warrigal Road Dr Helen Steiner 292 419A OAKLEIGH VIC 3166 Tel: 03 9568 7706 Fax: 03 9568 4498 E-Mail: oakeye13@bigpond.com DIABETIC RETINOPATHY DIABETES

More information

Retinal Tears and Detachments

Retinal Tears and Detachments Retinal Tears and Detachments Understanding Retinal Problems When your eyes are working well, it s easy to take them for granted. But a tear or detachment of your eye s retina (the light-sensing lining

More information

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care

The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Acute & Emergency Care November 2016 Association of Health Professions in Ophthalmology General

More information

Clinically Significant Macular Edema (CSME)

Clinically Significant Macular Edema (CSME) Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2

More information

Retinal pigment epithelial detachments in the elderly:

Retinal pigment epithelial detachments in the elderly: British Journal of Ophthalmology, 1985, 69, 397-403 Retinal pigment epithelial detachments in the elderly: classification and outcome A G CASSWELL, D KOHEN, AND A C BIRD From Moorfields Eye Hospital, City

More information

IMAGE OF THE MOMENT PRACTICAL NEUROLOGY

IMAGE OF THE MOMENT PRACTICAL NEUROLOGY 178 PRACTICAL NEUROLOGY IMAGE OF THE MOMENT Gawn G. McIlwaine*, James H. Vallance* and Christian J. Lueck *Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh UK; The Canberra Hospital, P.O. Box

More information

measure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control

More information

Primary Care Cataract Assessment Scheme

Primary Care Cataract Assessment Scheme Primary Care Cataract Assessment Scheme The intention of the scheme is to avoid unnecessary visits to Secondary Care for patients with cataract and to streamline the referral pathway. Under the scheme,

More information

X-Plain Diabetic Retinopathy Reference Summary

X-Plain Diabetic Retinopathy Reference Summary X-Plain Diabetic Retinopathy Reference Summary Introduction Patients with diabetes are more likely to have eye problems that can lead to blindness. Diabetic retinopathy is a disease of the eye s retina

More information

25% of normal 2/20/2018. Practical Guidelines for the Treatment of AMD 78% 22% Overview. AMD Information Overload

25% of normal 2/20/2018. Practical Guidelines for the Treatment of AMD 78% 22% Overview. AMD Information Overload I am a consultant / or have financial interest in: Practical Guidelines for the Treatment of Maculogix J&J Acuvue Vision Source Ocusoft Pogo Tech Jeffrey W. Jones, OD Longview, TX 75605 jjoneseye@gmail.com

More information

Extensive argon laser photocoagulation in the

Extensive argon laser photocoagulation in the British Journal of Ophthalmology, 1989, 73, 197-201 Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy G W AYLWARD, R V PEARSON, J D JAGGER, AND A M HAMILTON

More information